INmune Bio
INMB
INMB
82 hedge funds and large institutions have $6.09M invested in INmune Bio in 2026 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.1% more ownership
Funds ownership: 19.12% → 20.23% (+1.1%)
23% less capital invested
Capital invested by funds: $7.93M → $6.09M (-$1.85M)
Holders
82
Holding in Top 10
–
Calls
$55K
Puts
$38K
Top Buyers
| 1 | +$356K | |
| 2 | +$274K | |
| 3 | +$250K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$76K |
| 5 |
Jane Street
New York
|
+$39.9K |
Top Sellers
| 1 | -$173K | |
| 2 | -$111K | |
| 3 | -$80.5K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$80.3K |
| 5 |
JG
Jain Global
New York
|
-$65.6K |
